Use of Topotecan in Patients With Refractory Acute Leukemia
Status:
Completed
Trial end date:
2001-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify the highest tolerated doses in drugs used to treat
aggressive leukemia, lymphoma or multiple myeloma not responding to standard chemotherapy
treatment. The drugs being used in this study include drugs frequently used in treating such
diseases (mitoxantrone and etoposide) as well as a newer drug that has also been shown to be
effective (topotecan).
Phase:
Phase 2
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development